Malnutrition in Liver Cirrhosis

Why Nutrition Matters in Cirrhosis

Cirrhosis is the endstage of chronic liver disease, characterized by fibrosis, nodular regeneration, and loss of functional hepatic tissue. As the liver deteriorates, its ability to process nutrients, store glycogen, synthesize proteins, and regulate metabolism declines dramatically. Consequently, malnutrition is not just a side effectit is a predictor of morbidity, mortality, and poor quality of life.

Key Statistics

• Up to 60% of patients with compensated cirrhosis are malnourished; prevalence rises to >80% in decompensated disease.
• Malnutrition doubles the risk of hepatic decompensation (ascites, encephalopathy, variceal bleeding).
• Each 1g/kg/day loss in muscle mass is associated with a 1015% increase in 1year mortality.

Pathophysiology of Malnutrition in Cirrhosis

Multiple, interrelated mechanisms drive nutrient deficits:

• Decreased intake: Anorexia, early satiety from ascites, taste changes, and alcohol abuse.
• Malabsorption: Bile acid insufficiency impairs fat digestion; bacterial overgrowth and intestinal edema limit nutrient absorption.
• Altered metabolism: Impaired gluconeogenesis, reduced glycogen stores, and insulin resistance cause a catabolic state.
• Increased losses: Diuretics, paracentesis, and frequent therapeutic phlebotomy deplete protein and micronutrients.
• Inflammation: Cytokinedriven muscle protein breakdown (sarcopenia) is common.

Clinical Features

Recognizing malnutrition early is essential. Typical signs include:

• Weight loss >5% over 36months
• Muscle wasting (especially in the limbs and trunk)
• Low BMI (<18.5kg/m) or <23kg/m in Asians
• Reduced midarm circumference and handgrip strength
• Edema or ascites masking true weight loss
• Fatigue, weakness, and impaired immune response

Assessment Tools

Because fluid retention skews body weight, a combination of methods is recommended:

Anthropometry

• Midarm muscle circumference (MAMC)
• Handgrip dynamometry

Subjective Global Assessment (SGA)

A bedside tool that grades nutritional status as A (wellnourished), B (moderately malnourished), or C (severely malnourished). It incorporates history, weight change, dietary intake, and physical signs.

Imaging

• CT or MRI at the L3 vertebral level to calculate skeletal muscle index (SMI)
• Ultrasound can estimate muscle thickness when advanced imaging is unavailable.

Biochemical Markers

Serum albumin, prealbumin, transferrin, and vitamin levels are helpful but must be interpreted in the context of hepatic synthetic dysfunction.

Nutrition Goals

Practical Dietary Strategies

• Frequent small meals: 56 meals/snacks per day, with a lateevening carbohydrateprotein snack (e.g., milk + oatmeal).
• Highenergy beverages: Oral supplement drinks (250400kcal per serving) between meals.
• Protein timing: Distribute protein evenly across meals; include 2030g of highbiologicvalue protein per serving.
• Salt restriction: <2g/day to control ascites, but avoid excessive restriction that reduces appetite.
• Fluid management: Tailor intake to renal function; when ascites limits oral intake, consider therapeutic paracentesis with albumin replacement.
• Alcohol abstinence: Essential for halting further hepatic injury.

When Oral Intake Is Insufficient

Approximately 2030% of cirrhotic patients need supplemental nutrition.

Enteral Nutrition (EN)

Preferred route if the gastrointestinal tract is functional.

• Nasogastric or nasojejunal tube feeding.
• Polymeric formulas providing balanced macronutrients; consider diseasespecific formulas (MCTrich, highprotein, lowsodium).
• Start at 20% of goal calories and advance as tolerated.

Parenteral Nutrition (PN)

Reserved for patients with refractory gastrointestinal failure, uncontrolled ascites, or severe encephalopathy.

• Use a lipidemulsion containing fish oil to modulate inflammation.
• Monitor electrolytes, glucose, triglycerides, and liver enzymes closely.
• PN should be combined with early attempts to reestablish enteral intake.

Special Considerations

Sarcopenic Obesity

Patients may have a normal or high BMI but still suffer from severe muscle loss. In such cases, focus on protein enrichment and resistance exercise rather than calorie restriction.

Hepatic Encephalopathy (HE)

Traditional lactulosebased protein restriction is no longer recommended. Instead, maintain adequate protein and consider rifaximin or probiotics to modulate gut flora.

Renal Dysfunction

In hepatorenal syndrome or chronic kidney disease, adjust protein to 0.81.0g/kg/day and monitor electrolytes, especially potassium and phosphorus.

PostTransplant Nutrition

Early postoperative feeding (within 24h) promotes graft function and reduces infection risk. Target 3540kcal/kg/day and 1.5g/kg/day protein.

Role of Exercise

Combined resistance and aerobic training improves muscle mass, insulin sensitivity, and functional status. Recommended regimen:

• Resistance training 23 times/week (812 repetitions, major muscle groups).
• Aerobic activity (walking, cycling) 150minutes/week at moderate intensity.
• Supervision by a physiotherapist with experience in liver disease is ideal.

Monitoring and FollowUp

Nutrition status should be reassessed every 46weeks, or sooner after any decompensation event.

• Weight (dry weight when possible)
• Handgrip strength
• Serum albumin/prealbumin trends
• Micronutrient levels
• Compliance with oral supplements or tube feeds

Key Takeaways

1. Malnutrition is common and prognostically important in cirrhosis.
2. Assessment must combine clinical, anthropometric, and imaging tools.
3. Aim for 3035kcal/kg/day and 1.21.5g/kg/day protein, distributed across 56 meals.
4. Oral supplementation is firstline; use enteral nutrition before parenteral.
5. Address sarcopenia with resistance exercise and adequate protein, even in obese patients.

For further reading, consult the 2023 AASLD Guidelines on Nutrition in Liver Disease and the ESPEN Consensus on Enteral Nutrition in Cirrhosis.

For personalized advice, discuss your nutritional plan with a hepatologytrained dietitian.